fannininnovation.comCrawled Oct 16, 2026
This is not a public solicitation for the offering of any security. See “Disclosure” below.
The company is developing stealth technologies that are not yet listed in its pipeline.
The Product Development Associate Program, formerly Fannin’s Fellowship Program, provides life-science product development experience. Associates work on portfolio companies’ research and development, intellectual property, business development, regulatory affairs, and financing.
Philanthropic Support from Dr. Marie and Mr. Vijay Goradia Enables Research Collaboration to Study 11h in Alzheimer's Disease
Agenda and login instructions will be distributed prior to Investor Day.
Fannin's internship program offers hands-on operational experience in early-stage life science development through therapeutics, medical devices, and product development tracks. Interns work with portfolio companies on biomedical commercialization.
Established in 2014, Houston-based Fannin develops a dozen early-stage life sciences programs and platforms at different stages, internally and through Fannin-founded entities, with investor and grant funding.
Biomedical asset development while helping to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.
Biomedical asset development while helping to catalyze the formation of a thriving and sustainable life sciences entrepreneurship ecosystem for local and national markets.
The company’s privacy policy describes how it collects, uses, communicates, discloses, and otherwise handles personal information.
Fannin Partners, LLC's policy states that objective research supports public trust and the scientific, program, and ethical goals of its NIH grant efforts. It addresses financial interests held by biomedical and behavioral researchers.
The terms state that website access is subject to the terms, applicable laws, and local-law compliance, and that the site's materials are protected by copyright and trademark law.